DDPIC
NVO

Deroy & Devereaux Private Investment Counsel’s Novo Nordisk NVO Stock Holding History

Deroy & Devereaux Private Investment Counsel’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,408
Closed -$237K – 176
2025
Q1 		$237K Buy
+3,408
New +$281K 0.01% 155
2024
Q4 		– Sell
-2,700
Closed -$321K – 176
2024
Q3 		$321K Hold
2,700
– – 0.02% 146
2024
Q2 		$385K Sell
2,700
-900
-25% -$119K 0.02% 138
2024
Q1 		$462K Sell
3,600
-563
-14% -$67K 0.03% 136
2023
Q4 		$431K Sell
4,163
-2,737
-40% -$271K 0.03% 137
2023
Q3 		$627K Sell
6,900
-2,780
-29% -$245K 0.05% 114
2023
Q2 		$783K Buy
+9,680
New +$791K 0.05% 107

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Deroy & Devereaux Private Investment Counsel's NVO Position: Q2 2025 in Review

Deroy & Devereaux Private Investment Counsel sold out of Novo Nordisk (NVO) in Q2 2025, closing a stake of 3,408 shares — an estimated $237K sold.

Deroy & Devereaux Private Investment Counsel first reported a position in NVO in Q2 2023 and held it in 7 quarters. The position peaked at $783K in Q2 2023. 1,482 funds tracked by Wall St. Rank hold NVO as of Q2 2025.

  • Deroy & Devereaux Private Investment Counsel reported no remaining Novo Nordisk position as of Q2 2025 after selling out during the quarter.
  • Deroy & Devereaux Private Investment Counsel sold 3,408 Novo Nordisk shares in Q2 2025, an estimated $237K.
  • Deroy & Devereaux Private Investment Counsel first reported a position in Novo Nordisk in Q2 2023 and held it in 7 quarters.
  • Deroy & Devereaux Private Investment Counsel's Novo Nordisk position peaked at $783K in Q2 2023.
  • 1,482 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.

Based on Deroy & Devereaux Private Investment Counsel's 13F filing for Q2 2025, filed 28 Jul 2025.